LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWuxi Hisky Medical Technology Co Ltd
About this trial
To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.
Eligibility criteria
Qualifiers
Patients diagnosed with NAFLD according to The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases;
Age over 18 years old, gender not limited;
Not combined with liver diseases (such as viral hepatitis, drug-induced liver injury, autoimmune liver disease);
Perform iLivTouch examination within ± 14 days of liver pathology examination;
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Wuxi Hisky Medical Technology Co Ltd
Lead sponsor
Beijing Tsinghua Changgeng Hospital
Collaborator
Source ClinicalTrials.gov